Authors
Shuangshuang Wang, Zewen Liu, Keli Yang, Jiajia Zhu, Wei Liu, Yongxiang Tian, Qiong Wu, Ting Gao, Chang Li, Fangyan Yuan, Danna Zhou
Published in
Vaccine. Volume 96. Pages 129341. Nov 14, 2026. Epub Nov 14, 2026.
Abstract
Enterotoxigenic Escherichia coli (ETEC) is an important bacterial pathogen causing neonatal piglet diarrhea. Traditional vaccines, however, are limited by narrow serotype coverage and complex inactivated whole-cell compositions, highlighting the need for novel multivalent vaccines. Here, we used ETEC fimbriae as an antigen-display scaffold to achieve bivalent co-presentation by displaying the K99-FanC epitope on the K88-FaeG subunit via PRE112-mediated allelic exchange, generating the ETEC K88(FaeG)-K99(FanC) strain (bivalent chimeric strain). The resulting strain and its fimbrial protein were evaluated for biological characteristics, physicochemical properties, immunogenicity, and protective potential. The bivalent chimeric fimbriae assembled into typical filamentous structures with adhesive properties comparable to the parental strain (p > 0.05). The purified chimeric fimbrial protein exhibited an apparent molecular weight equivalent to the parental counterpart, yet displayed increased particle size and aggregation. Both were specifically recognized by anti-K88 and anti-K99 serum. The chimeric fimbrial protein induced dual-specific antibodies against K88 and K99. K99-specific IgG titers were significantly higher than those elicited by both the physical mixture of native fimbriae (p < 0.01) and the commercial vaccine (p < 0.001), as were K99-specific IgA titers relative to the commercial vaccine (p < 0.01). In contrast, K88-specific IgG and IgA titers were comparable to those of the commercial vaccine (p > 0.05). In vitro, immune serum blocked adhesion of both serotypes, with K99 inhibition superior to the commercial vaccine (p < 0.01). Following challenge with K99 (2 × 101⁰ CFU) or K88 (2 × 107 CFU), immunized mice exhibited significantly reduced cecal bacterial counts (p < 0.001) and no apparent jejunal pathology. FaeG and FanC-specific antibodies were simultaneously detected in the immune serum, confirming that bivalent epitopes participated in the immune response. Collectively, the bivalent chimeric fimbrial protein provides a promising antigen-integration strategy for the development of multivalent ETEC subunit vaccines.
PMID:
43033781
Bibliographic data and abstract were imported from PubMed on 15 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 7
- Comments 0